Pharmacokinetics and bioavailability of sustained release melatonin tablets in healthy dogs by HPLC-MS
HE Zhong-gui
Abstract
HE Zhong-gui
Abstract
OBJECTIVE To compare data of pharmacokinetics and bioavailability between sustained release melatonin tablets and commercial tablets.METHODS A single oral dose of 6 mg test or reference preparations was given to 6 healthy dogs in a randomized crossover study. The serum concentrations of melatonin were determined by HPLC-MS method. RESULTS The pharmacokinetic parameters of two kinds of tablets were as Mows:tmax(2.08±0.20),(1.13±0.59) h;ρmax(4.66±6.87),(6.54±6.16)μg·L-1;AUC(13.21±17.21),(11.48± 5.37)μg·h·L-1.CONCLUSION The relative bioavailability of sustained release tablets is(87.79±72.68)% compared with the commercial tablets.The two formulations are bioequivalent.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
OBJECTIVE To compare data of pharmacokinetics and bioavailability between sustained release melatonin tablets and commercial tablets.METHODS A single oral dose of 6 mg test or reference preparations was given to 6 healthy dogs in a randomized crossover study. The serum concentrations of melatonin were determined by HPLC-MS method. RESULTS The pharmacokinetic parameters of two kinds of tablets were as Mows:tmax(2.08±0.20),(1.13±0.59) h;ρmax(4.66±6.87),(6.54±6.16)μg·L-1;AUC(13.21±17.21),(11.48± 5.37)μg·h·L-1.CONCLUSION The relative bioavailability of sustained release tablets is(87.79±72.68)% compared with the commercial tablets.The two formulations are bioequivalent.
Key concepts: Bioequivalence, Bioavailability, Pharmacokinetics, Crossover study, Pharmacology, Melatonin, High-performance liquid chromatography, Chemistry